These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 15581944)
1. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice. Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944 [TBL] [Abstract][Full Text] [Related]
2. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545 [TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Määttä M; Soini Y; Liakka A; Autio-Harmainen H Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717 [TBL] [Abstract][Full Text] [Related]
5. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions. Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression. Torng PL; Mao TL; Chan WY; Huang SC; Lin CT Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248 [TBL] [Abstract][Full Text] [Related]
7. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284 [TBL] [Abstract][Full Text] [Related]
8. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005 [TBL] [Abstract][Full Text] [Related]
9. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Hofmann UB; Eggert AA; Blass K; Bröcker EB; Becker JC Cancer Res; 2003 Dec; 63(23):8221-5. PubMed ID: 14678978 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249 [TBL] [Abstract][Full Text] [Related]
12. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors. Nakada M; Nakamura H; Ikeda E; Fujimoto N; Yamashita J; Sato H; Seiki M; Okada Y Am J Pathol; 1999 Feb; 154(2):417-28. PubMed ID: 10027400 [TBL] [Abstract][Full Text] [Related]
13. Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells. Ohnishi Y; Tajima S; Ishibashi A Eur J Dermatol; 2001; 11(5):420-3. PubMed ID: 11525948 [TBL] [Abstract][Full Text] [Related]
14. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Fishman DA; Bafetti LM; Stack MS Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550 [TBL] [Abstract][Full Text] [Related]
15. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human urothelial carcinomas. Kitagawa Y; Kunimi K; Ito H; Sato H; Uchibayashi T; Okada Y; Seiki M; Namiki M J Urol; 1998 Oct; 160(4):1540-5. PubMed ID: 9751409 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13. Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360 [TBL] [Abstract][Full Text] [Related]
17. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]. Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of stromal metalloproteinases and vascular endothelial growth factors in a spontaneous metastasis model. Donadio AC; Durand S; Remedi MM; Frede S; Ceschin DG; Genti-Raimondi S; Chiabrando GA Exp Mol Pathol; 2005 Dec; 79(3):259-64. PubMed ID: 16188254 [TBL] [Abstract][Full Text] [Related]
19. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependent tumor growth in mice. Taniwaki K; Fukamachi H; Komori K; Ohtake Y; Nonaka T; Sakamoto T; Shiomi T; Okada Y; Itoh T; Itohara S; Seiki M; Yana I Cancer Res; 2007 May; 67(9):4311-9. PubMed ID: 17483344 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]